USS Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.99M Buy
683,981
+629,840
+1,163% +$8.32M 0.04% 299
2026
Q1
$746K Buy
54,141
+3,513
+7% +$52.9K ﹤0.01% 501
2025
Q4
$913K Buy
50,628
+18,590
+58% +$334K ﹤0.01% 498
2025
Q3
$594K Hold
32,038
﹤0.01% 518
2025
Q2
$512K Hold
32,038
﹤0.01% 518
2025
Q1
$623K Hold
32,038
﹤0.01% 526
2024
Q4
$706K Buy
+32,038
New +$617K ﹤0.01% 549

Other funds holding CLBT

USS Investment Management's CLBT Position: Q2 2026 in Review

USS Investment Management increased its Cellebrite (CLBT) stake by 1,163% in Q2 2026, buying an estimated $8.32M and bringing the position to 683,981 shares worth $9.99M. The position accounts for 0.04% of the portfolio, ranked #299.

USS Investment Management first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • USS Investment Management held 683,981 shares of Cellebrite worth $9.99M as of Q2 2026.
  • USS Investment Management bought 629,840 Cellebrite shares in Q2 2026, an estimated $8.32M.
  • Cellebrite made up 0.04% of USS Investment Management's portfolio in Q2 2026, its #299 holding.
  • USS Investment Management first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.